October 2021
Price: £95 PLUS VAT
Format: DOWNLOADABLE PDF
This conference focused on next steps for the integration of community pharmacy with primary care - as well as the response to COVID-19 and lessons to take forward, and progress and next steps for the Community Pharmacy Contractual Framework.
It took place following the announcement of the Community Pharmacy Contractual Framework for Year 3 2021-2022, which sets out the priorities for the year ahead, including around supporting integration, efficiencies, and the use of digital technology, as well as the role of pharmacy in recovery from the pandemic, supporting general practice with managing demand, and delivering health promotion and prevention.
Overall, areas for discussion included:
- the Community Pharmacy Contractual Framework - progress, latest developments, and priorities going forward
- pharmacy staff training and development - looking at priorities, including in the context of their developing clinical role, with new GPhC standards for pharmacist initial education and training
- the response to COVID-19 - what can be learned and taken forward from the role played by pharmacy, looking at:
- adapting practice and prioritising vulnerable individuals
- delivering the COVID-19 vaccination programme
- providing local and accessible places for people within the community
- public health policy developments - the role of community pharmacy within primary care networks, including patient safety, improving prevention, and moving forward on integration and the plans outlined in the Health and Care Bill, as well as providing continuity of care
- innovation - looking at how pharmacies are evolving and the implications for care and the workforce, the future use of digital technology, and opportunities and next steps for optimising pharmacy delivery
Attendees
Our forums are known for attracting strong interest from policymakers and stakeholders. Places were reserved by parliamentary pass-holders from the House of Lords, and officials from the Department of Health and Social Care; the Department for International Trade; the DWP; the Government Legal Department; the National Audit Office; and the States of Guernsey. Representatives who also attended were from Becton Dickinson; BMICircle; Boehringer Ingelheim; Boots UK; Brabners; Central Bedfordshire Council; Dudley Local Pharmaceutical Committee; General Pharmaceutical Council; GlaxoSmithKline; Heart Valve Voice; Keele University; Kingsley Napley; KSS Academic Health Science Network; Marwood Group; Medway Council; Midlands Partnership Foundation NHS Trust; Newcastle University; North Hampshire Urgent Care; Organon; Pfizer; Public Health England; Res Consortium; Sempergens; Suffolk County Council; Sussex University; Teva UK; University of Sussex; University of Nottingham; Viatris; Walgreens Boots Alliance; Ward Hadaway; Westminster Drug Project; and Wyre Forest Health Partnership.
Press passes had been reserved by representatives from Chemist + Druggist; MGP; Pharmacy Business; Pharmacy Magazine; SasaWrites; The Pharmaceutical Journal; and The Pharmacist Magazine.
